Relapsing Kaposi's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis.
D000212:Acyclovir / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005145:Face; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007617:Kaposi Varicelliform Eruption / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D009824:Ointments; D012008:Recurrence; D018139:Simplexvirus / Q000502:physiology*; D016559:Tacrolimus / Q000009:adverse effects*; D014775:Virus Activation
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D009824:Ointments; D016559:Tacrolimus; D000212:Acyclovir